PRGO Q1 2020 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena

PRGOPerrigo Company plc

$1B

Q1 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.1B-7.8% YoY

Gross Profit

$394M36.3% margin

Operating Income

$86M8.0% margin

Net Income

$106M9.8% margin

EPS (Diluted)

$0.77

QoQ Revenue Growth

-18.1%

Cash Flow

Operating Cash Flow

$172M

Free Cash Flow

$138M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$11.4B

Total Liabilities

$5.6B

Stockholders' Equity

$5.8B

Cash & Equivalents

$510M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$1.2B	-7.8%
Gross Profit	$394M	$449M	-12.3%
Operating Income	$86M	$102M	-15.5%
Net Income	$106M	$64M	+66.5%

Revenue Segments

Consumer Self-Care Americas

$701M52%

Consumer Self-Care International

$383M29%

RX Pharmaceuticals

$258M19%

Geographic Segments

UNITED STATES

$902M67%

Europe

$373M28%

Other Geographical Areas

$67M5%

IRELAND

$4M0%